Palisade Bio to Participate in Upcoming Investor Conferences
Palisade Bio plans multiple September 2026 investor presentations, with live webcasts and replays available through its investor relations website.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Palisade Bio (PALI) will participate in three healthcare investor conferences in September 2026, including events hosted by Wells Fargo, Morgan Stanley and H.C. Wainwright.
The Morgan Stanley fireside chat is on September 16, 2026, 10:00–10:35 AM ET in New York. The H.C. Wainwright presentation is on September 16, 2026, 3:00–3:30 PM ET in New York. Live webcasts and limited-time replays will be available on the Investors section of palisadebio.com.
Details
News Market Reaction – PALI
On Sep 3, the day this news came out, PALI closed 2.76% above the previous close. Our momentum scanner recorded 3 alerts in the available session data. Relative volume reached 1.8x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 3 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Denver, CO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases, today announced that members of management will participate in three healthcare investor conferences in September 2026.
Wells Fargo 2026 Healthcare Conference
Dates: September 8–10, 2026
Location: Boston, Massachusetts
Format: Investor meetings
Morgan Stanley 24th Annual Global Healthcare Conference
Dates: September 14–16, 2026
Location: New York, New York
Fireside Chat: Wednesday, September 16, 2026, from 10:00–10:35 AM ET
Format: In-person fireside chat and investor meetings
Webcast Registration
H.C. Wainwright 28th Annual Global Investment Conference
Dates: September 14–16, 2026
Location: New York, NY
Presentation: Wednesday, September 16, 2026, from 3:00–3:30 PM ET
Presentation Location: Kennedy II, 4th Floor
Format: In-person fireside chat and investor meetings
Webcast Registration
Investors interested in meeting with Palisade Bio management during the conferences should contact their respective conference representatives.
Live webcasts of the fireside chats will be accessible on the Events page in the Investors section of the Company’s website at palisadebio.com. Replays will be available following the live events and will be archived for a limited time.
About Palisade Bio
Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company developing prodrugs for patients living with inflammatory and fibrotic diseases.
The Company’s lead clinical product candidate, PALI-2108, is being advanced into Phase 2 clinical trials as a treatment for patients living with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). Despite the availability of multiple biologic and small-molecule therapies, many patients with UC and CD do not achieve durable remission, lose response over time, or discontinue treatment because of safety or tolerability limitations. The Company believes PALI-2108 has the potential to address these limitations through once-daily oral dosing, targeted lower-intestinal bioactivation and broad PDE4-mediated anti-inflammatory activity.
For more information, please go to www.palisadebio.com.
Investor Relations Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.